TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
459
|
545
|
491 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
289
|
500
|
351 |
EBITDA |
241
|
500
|
351 |
Total assets |
3,009
|
2,858
|
2,727 |
Current assets |
2,101
|
1,954
|
1,745 |
Current liabilities |
70
|
82
|
53 |
Equity capital |
2,789
|
2,637
|
2,539 |
- share capital |
5
|
4
|
5 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.7%
|
92.3%
|
93.1% |
Turnover per employee |
230
|
272
|
246 |
Profit as a percentage of turnover |
63.0%
|
91.7%
|
71.5% |
Return on assets (ROA) |
9.6%
|
17.5%
|
12.9% |
Current ratio |
3001.4%
|
2382.9%
|
3292.5% |
Return on equity (ROE) |
10.4%
|
19.0%
|
13.8% |
Change turnover |
-87
|
94
|
-176 |
Change turnover % |
-16%
|
21%
|
-26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.